The independent source for health policy research, polling, and news.
2,181 - 2,200 of 3,484 Results
With Republicans in control of Congress and the White House, HSAs — a longtime favorite of conservatives — are likely to get a boost.
According to a settlement four years ago, Medicare was supposed to make clear to therapists that their services are covered even if beneficiaries are not improving. But that is not yet widely accepted.
Researchers believe Californians, many of whom lost health coverage, delayed doctor visits that could have led to earlier detection. Now, with people seeking medical care under the Affordable Care Act, some experts expect to see an increase in late-stage cancers.
Kaiser Health News is working with ProPublica and other news organizations to collect and analyze letters and emails from elected officials to constituents on the ACA, beginning with a misleading missive by Missouri Sen. Roy Blunt. Send us more!
High deductibles and other out-of-pocket costs related to health insurance have become a rising concern among consumers and health-care providers.
Wood, who chairs the Assembly Health Committee, lays out his priorities for 2017.
Ford Inbody has a degenerative disease and is carefully watching the GOP replacement health care bill. Though it covers preexisting conditions, it could still mean he'll get less care for more money.
“Portability” will likely be a buzz word in the health law repeal-and-replace debate, but the concept raises a number of complicated policy issues.
An analysis by the Congressional Budget Office offers an estimate of the effects of the repeal plan offered by congressional Republican in 2015, which may be a blueprint for efforts currently underway to overhaul the health law.
At their party retreat, the officials are coalescing around a strategy that would have not a single replacement for the Affordable Care Act but instead include changes through a budget bill, administrative action and later a series of individual bills addressing smaller aspects of the health system.
Rep. Tom Price, up for running HHS under President Trump, helped a company that became a top campaign donor, records show.
Former FDA Commissioner Dr. Robert Califf shares his views about drug approvals, regulations and safety concerns after stepping down from the giant agency.
Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
The Trump administration’s first health regulation would shorten the enrollment periods and make it harder for patients to get coverage outside of that annual signup period.
A bill recently introduced in the California legislature would require insurance companies to cover fertility-preserving services for patients at risk of infertility because of necessary medical treatments.
The state has one of the highest rates of small business owners who get health coverage through the Affordable Care Act.
Donald Trump’s pick to run HHS has been under fire for trading health care stocks but at least six senators at his confirmation hearings also own such stocks.
Rep. Tom Price advocated on everything from a sperm test to a hot pepper ingredient on behalf of medical interests that included campaign donors.
A new report finds that major insurers like Aetna and UnitedHealth submitted conflicting lists to the state that were off by thousands of doctors.
The medical supply industry makes a particularly revelatory case study of the difficulties of untangling global trade.
© 2026 KFF